Indivior Advances Addex's GABAB PAM Program Through IND Enabling Studies

Indivior, partnering with Addex Therapeutics, successfully completed IND-enabling studies for a GABAB positive allosteric modulator (PAM) targeting su...
Home/KnloSights/Clinical Trial Updates/Indivior Advances Addex's GABAB PAM Program Through IND Enabling Studies